Technology Stocks
MGNX -- MacroGenics
An SI Board Since November 2013
Posts SubjectMarks Bans Symbol
37 27 0 MGNX
Emcee:  scaram(o)uche Type:  Moderated
CD123-related abstract (preclinical) coming up at ASH, so maybe it's time for a thread. DART is a very old concept.... I was one of the first to try it, but the original concept came from Dartmouth and served as the foundation science for Medarex.

MGD006, Servier has right to license for some geographies.....

One more ASH abstract, not from MGNX.......

Pointer to the pipeline chart, website.....

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
37So far, mediocre volume trade after 1.1M share offer to Investor @21.5????Miljenko ZuanicApril 27
36>> MGA271 was well tolerated, with no dose-limiting toxicity and no maximscaram(o)uche11/4/2015
35Just when I start to get excited about a late-breaker, Servier says "we'scaram(o)uche10/28/2015
34Interim look, phase I trial? Late breaker, and it IS a 150 ptient trial. I wasscaram(o)uche10/2/2015
33Lots of business plan progress, see PRs since 5/28. Today's news...... Macscaram(o)uche7/15/2015
32MacroGenics Preclinical Research on MGD006 DART(R) Molecule Published in Sciencescaram(o)uche5/28/2015
31<Janssen will invest $75M in MacroGenics via the purchase of 1,923,077 sharesBiotech Jim12/22/2014
30MacroGenics Enters Collaboration and License Agreement with Janssen to Develop Mscaram(o)uche12/22/2014
29Thanks Rick and Tuck. took profits here @ 34.50. look for another entry point.mopgcw12/18/2014
28>>Patient enrollment continues in the Company's exploratory Phase 2a stuck11/12/2014
27 Data at EORTC-NCI-AACR (poster, 19 November)...... Preclinical activity and sascaram(o)uche10/30/2014
26F-star Alpha news.... Message 29779136scaram(o)uche10/28/2014
25>> MacroGenics (NASDAQ:MGNX) shares reached a new 52-week low on Monday , scaram(o)uche10/14/2014
24MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additscaram(o)uche9/29/2014
23Thanks, wasn't sure I'd get to the CC for over a week, and none of that tuck8/7/2014
22>> fallen behind a previously given schedule? << Yes, margetuximab.scaram(o)uche8/6/2014
21>>MacroGenics Provides Update on Corporate Progress and Second Quarter 201tuck8/6/2014
20ROCKVILLE, Md. and OSAKA, Japan, May 27, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inigel bates5/27/2014
19Coming at ASCO14 (2 June 8 a.m.)...... Abstract #TPS671^ A single arm, open-scaram(o)uche4/21/2014
18>> But I haven't bought any, no. I'll let a Friday (tomorrow) playscaram(o)uche4/16/2014
17I didn't play follow the bouncing ball at IH. Only followed your pointer toscaram(o)uche4/15/2014
16I took a look at the MGNX paper, cited here along with the supplemental data citBiotech Jim4/14/2014
15Interesting conversation on MGNX drug versus simpler mAbs targeting B7H3, and ttuck4/13/2014
14Despite the lockup expiry, I bit the bullet and just initiated my MGNX starter pBiotech Jim4/11/2014
13Jim, I use this site for lockup expirations.... Might be scaram(o)uche4/10/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.